Over the past 20 years, inhaled corticosteroids have become established as cornerstone therapy in the treatment of obstructive pulmonary disorders, ranging from asthma and chronic obstructive pulmonary disease to cystic fibrosis.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.